Literature DB >> 8111589

Bacteremic necrotizing pneumococcal pneumonia in children.

E Kerem1, Y Bar Ziv, B Rudenski, S Katz, D Kleid, D Branski.   

Abstract

Necrotizing pneumonia, massive necrosis of lung tissue, is a serious, often fatal, complication of lobar pneumonia. Four children 1.3 to 7.5 yr of age were hospitalized with bacteremic pneumococcal pneumonia. All of them were acutely ill on presentation with arterial desaturation, and they developed anemia and thrombocytosis. Two patients had pleural effusion requiring drainage. A chest CT scan revealed segmental or lobar pulmonary liquification, which led to the diagnosis of necrotizing pneumonia. This finding could be demonstrated early in the course of the disease. Subsequently, all of the patients developed cavitating lesions. With adequate antipneumococcal therapy and/or chest tube drainage, all of the patients recovered completely; however, clinical improvement was prolonged: fever lasted 9 to 20 days, and length of hospitalization was 12 to 26 days. Contrary to that in adults, complete recovery is anticipated in children with bacteremic necrotizing pneumococcal pneumonia, and no invasive investigations are required.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8111589     DOI: 10.1164/ajrccm.149.1.8111589

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  10 in total

Review 1.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

2.  Demise of lung transplants: exposing critical gaps in understanding lung stem cells.

Authors:  Wa Xian; Frank McKeon
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

3.  Pneumococcal necrotizing pneumonia in Utah: does serotype matter?

Authors:  Jeffrey M Bender; Krow Ampofo; Kent Korgenski; Judy Daly; Andrew T Pavia; Edward O Mason; Carrie L Byington
Journal:  Clin Infect Dis       Date:  2008-05-01       Impact factor: 9.079

4.  Surgical treatment of pediatric lung abscess.

Authors:  M H Wu; Y L Tseng; M Y Lin; W W Lai
Journal:  Pediatr Surg Int       Date:  1997-04       Impact factor: 1.827

5.  Necrotizing pneumonia caused by refractory Mycoplasma pneumonia pneumonia in children.

Authors:  Xia Wang; Li-Jia Zhong; Zhi-Min Chen; Yun-Lian Zhou; Bei Ye; Yuan-Yuan Zhang
Journal:  World J Pediatr       Date:  2018-06-11       Impact factor: 9.186

Review 6.  Necrotizing pneumonia: an emerging problem in children?

Authors:  I Brent Masters; Alan F Isles; Keith Grimwood
Journal:  Pneumonia (Nathan)       Date:  2017-07-25

7.  p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration.

Authors:  Wei Zuo; Ting Zhang; Daniel Zheng'An Wu; Shou Ping Guan; Audrey-Ann Liew; Yusuke Yamamoto; Xia Wang; Siew Joo Lim; Matthew Vincent; Mark Lessard; Christopher P Crum; Wa Xian; Frank McKeon
Journal:  Nature       Date:  2014-11-12       Impact factor: 49.962

8.  miR-140-5p Overexpression Protects Against Lipopolysaccharide-Induced Necrotizing Pneumonia via Targeting Toll-Like Receptor 4.

Authors:  Haichao Wang; Changhao Wu; Dehui Kong
Journal:  Cell Mol Bioeng       Date:  2021-05-10       Impact factor: 2.321

9.  Whole Exome Sequencing Identifies New Host Genomic Susceptibility Factors in Empyema Caused by Streptococcus pneumoniae in Children: A Pilot Study.

Authors:  Antonio Salas; Jacobo Pardo-Seco; Ruth Barral-Arca; Miriam Cebey-López; Alberto Gómez-Carballa; Irene Rivero-Calle; Sara Pischedda; María-José Currás-Tuala; Jorge Amigo; José Gómez-Rial; Federico Martinón-Torres
Journal:  Genes (Basel)       Date:  2018-05-03       Impact factor: 4.096

10.  The value of chest magnetic resonance imaging compared to chest radiographs with and without additional lung ultrasound in children with complicated pneumonia.

Authors:  Philip Konietzke; Jan Mueller; Felix Wuennemann; Willi L Wagner; Jens-Peter Schenk; Abdulsattar Alrajab; Hans-Ulrich Kauczor; Mirjam Stahl; Marcus A Mall; Mark O Wielpütz; Olaf Sommerburg
Journal:  PLoS One       Date:  2020-03-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.